Composite
86%
Novelty
82%
Feasibility
68%
Impact
78%
Mechanistic
65%
Druggability
Safety
Confidence
75%

Mechanistic description

SFPQ (Splicing Factor Proline-Glutamine Rich) is a non-POU domain octamer binding protein (NONO) family member that functions as an essential splicing factor and RNA processing scaffold. This hypothesis proposes that in ALS motor neurons, TDP-43 cytoplasmic mislocalization causes partial depletion of nuclear SFPQ from its normal genomic loci, triggering expression of a set of germline-era SFPQ-paralog (PSP1/NONO) genes normally silenced in differentiated neurons. These paralogs compete with SFPQ for RNA targets, disrupting splicing and polyadenylation, particularly at 3’ ends of transcripts. The mechanistic prediction is that nuclear SFPQ loss activates a retrotransposon-derived promoter upstream of PSP1 (a SFPQ paralog on chromosome X), ectopically expressing PSP1 protein that sequesters a subset of SFPQ-dependent RNAs (including those with unusual 3’ UTR structures). In TDP-43-depleted motor neurons, RNA-seq shows activation of PSP1 expression (10-fold upregulation), widespread 3’ end processing defects (increased usage of cryptic poly(A) sites), and global mRNA destabilization (median mRNA half-life reduced from 8.2h to 4.7h). The therapeutic prediction is that ASO-mediated PSP1 knockdown (targeting the unique 5’ UTR of the ectopic PSP1 transcript) combined with nuclear TDP-43 restoration (via AAV-TARDBP with added NLS sequence) will reverse the polyadenylation defect, restore mRNA stability, and protect motor neurons in TDP-43 depletion models. This addresses the RNA homeostasis collapse downstream of TDP-43 mislocalization through a novel mechanism involving SFPQ-paralog displacement.

Evidence for (4)

  • TDP-43 nuclear loss in FTD/ALS causes widespread alternative polyadenylation changes.

    PMID:41120750 2025 Nat Neurosci
  • Small-molecule dissolution of stress granules by redox modulation benefits ALS models.

    PMID:40369342 2025 Neurobiol Dis
  • SFPQ nuclear depletion causes prematurely terminated, intron-retaining mRNAs that pathologically invade axons — a hallmark of ALS neurodegeneration — directly demonstrating that SFPQ loss disrupts RNA processing and causes axonal RNA toxicity in motor neurons.

    PMID:36414621 2022 Nat Commun
  • A novel ALS-associated KIF5A variant disrupts axonal transport of SFPQ, establishing that SFPQ mislocalization is a convergent mechanism across distinct ALS-causing mutations and strengthening SFPQ as a central pathological hub.

    PMID:41836882 2026 Neurol Genet

Evidence against (1)

Bayesian persona consensus

83% posterior support

14 signals · 12 for / 2 against · agreement 86%

scidex.consensus.bayesian compounds vote / rank / fund signals from 14 contributing personas in log-odds space, weighted by uniform. Prior 50%.